Snowball logo
logo
AQST

Aquestive Therapeutics Inc

AQST β€’ NASDAQ
$4.78+$0.17Β  (3.69%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
50.8347.6850.5857.5644.5554.09
COGS
14.9919.3920.8317.8717.1517.83
Gross Profit
35.8428.2929.7539.6927.3936.26
Operating Expenses & Income
Operating Income
(34.68)(42.07)(15.1)(30.77)(69.65)(52.74)
Total Operating Expenses
70.5270.3644.8570.4697.0489
R&D Expenses
17.0517.4813.120.2817.1915.89
Selling General & Admin Expenses
53.4852.8831.7550.1879.8570.94
Earnings from Continuing Operations
Interest Expense
(22.46)(12.44)(7.462)(16.82)(17.1)(16.32)
Interest Income
0.4230.09916.323.4374.3672.523
Income Tax Expense
19.55.7920.245(0.014)--
Net Income
Net Income
(70.54)(54.41)(7.87)(44.14)(83.78)(78.23)
Supplemental
EBIT
(48.08)(41.97)(0.163)(27.33)(66.68)(61.91)
EBITDA
(45.11)(39.58)1.182(26.62)(66.13)(61.27)
In millions of USD, except % and values per 1 share